The Human Interactome Falls into place

a first draft, so to speak, of protein-protein interactions, the subject of the story on the pages that follow.

Written byAlison McCook
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Two years after the completion of the human genome, the human "interactome" is coming together – a first draft, so to speak, of protein-protein interactions, the subject of the story on the pages that follow. The interactome efforts came from humble beginnings, based on work on much smaller organisms, C. elegans and Drosophila, as described onpage18. And just as the results of genomics efforts on those organisms were hotly debated, says systems biology researcher Marc Vidal, some researchers are strongly opposed to the human interactome. No matter how they feel about the project, however, researchers want to see their proteins in the maps that Vidal and his colleagues are working to complete. Onpage 20, Herbert M. Sauro looks into the future and demonstrates just how inadequate such data accumulation tasks can be when trying to piece together the whole picture through systems biology models.

Two years ago the Human Genome ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform